Bloomberg: Stent Experts Have Ties to Industry

The FDA is probing the safety of drug-coated stents after some data indicate an increased risk of blood clots among patients with the stents.  Bloomberg reports that six of the experts on the panel put together to consider the data have financial ties to J&J or Boston Scientific, two stent-makers.  The FDA has waived conflicts rules to permit them on the panel.